Orexo eyes opioid use disorder app launch before year-endSweden’s Orexo says its opioid use disorder (OUD) digital therapeutic – now christened Modia – is on course Share XOrexo eyes opioid use disorder app launch before year-endhttps://pharmaphorum.com/news/orexo-eyes-opioid-use-disorder-app-launch-before-year-end/
After final $600M opioid settlement, Indivior looks to the futureUK drugmaker Indivior looks finally to have put years of uncertainty over its exposure to opioid litigation in Share XAfter final $600M opioid settlement, Indivior looks to the futurehttps://pharmaphorum.com/news/after-final-600m-opioid-settlement-indivior-looks-to-the-future/
Mallinckrodt proposes $1.6bn deal to settle opioid litigationMallinckrodt is placing a $1.6 billion settlement package on the table as it tries to bring litigation related Share XMallinckrodt proposes $1.6bn deal to settle opioid litigationhttps://pharmaphorum.com/news/mallinckrodt-proposes-1-6bn-deal-to-settle-opioid-litigation/
FDA rejects Adamis opioid overdose therapy Zimhi, hitting share priceShares in Adamis Pharmaceuticals have been poleaxed by an FDA decision to reject Zimhi, intended as a treatment Share XFDA rejects Adamis opioid overdose therapy Zimhi, hitting share pricehttps://pharmaphorum.com/news/fda-rejects-adamis-opioid-overdose-therapy-zimhi-hitting-share-price/
Federal opioid trial averted by last-ditch settlementTeva and three pharma wholesalers have agreed a $260 million settlement with two Ohio counties over their role Share XFederal opioid trial averted by last-ditch settlementhttps://pharmaphorum.com/news/federal-opioid-trial-averted-by-last-ditch-settlement/
Is the US opioid litigation nearing an end game?Drugmakers, wholesalers and lawmakers in the US are said to be thrashing out the details of a big Share XIs the US opioid litigation nearing an end game?https://pharmaphorum.com/news/is-the-us-opioid-litigation-nearing-an-end-game/
Sandoz says ‘no’ to Pear Therapeutics’ digital apps, handing back rightsNovartis has made no secret of its desire to become a leader in digital therapeutics (DTx), but that Share XSandoz says ‘no’ to Pear Therapeutics’ digital apps, handing back rightshttps://pharmaphorum.com/news/sandoz-says-no-to-pear-therapeutics-digital-app-handing-back-rights/
J&J settles Ohio lawsuits for $20m as opioid litigation train rumbles onJohnson & Johnson has managed to put opioid litigation in Ohio behind it with a $20 million settlement, Share XJ&J settles Ohio lawsuits for $20m as opioid litigation train rumbles onhttps://pharmaphorum.com/news/jj-settles-ohio-lawsuits-for-20m-as-opioid-litigation-train-rumbles-on/
Purdue presses ahead with bankruptcy filingAs expected, Purdue Pharma has formally filed for bankruptcy protection as it tries to resolve thousands of lawsuits Share XPurdue presses ahead with bankruptcy filinghttps://pharmaphorum.com/news/purdue-presses-ahead-with-bankruptcy-filing/
